Common variable immunodeficiency: autoimmune cytopenias and advances in molecular diagnosis

2.

Bonilla

FA

,

Barlan

I

,

Chapel

H

, et al.

International Consensus Document (ICON): common variable immunodeficiency disorders

.

J Allergy Clin Immunol Pract

.

2016

;

4

(

1

):

38

-

59

.

3.

Seidel

MG

,

Kindle

G

,

Gathmann

B

, et al.

The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity

.

J Allergy Clin Immunol Pract

.

2019

;

7

(

6

):

1763

-

1770

.

4.

Seidel

MG

,

Kindle

G

,

Gathmann

B

, et al;

ESID Registry Working Party and collaborators

.

The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

.

J Allergy Clin Immunol Pract

.

2019

;

7

(

6

):

1763

-

1770

.

5.

Allain

V

,

Grandin

V

,

Meignin

V

, et al.

Lymphoma as an exclusion criteria for CVID diagnosis revisited

.

J Clin Immunol

.

2023

;

43

(

1

):

181

-

191

.

6.

Jolles

S

,

Chapel

H

,

Litzman

J.

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach

.

Clin Exp Immunol

.

2017

;

188

(

3

):

333

-

341

.

7.

Gathmann

B

,

Mahlaoui

N

,

Gérard

L

, et al;

CEREDIH; Dutch WID; European Society for Immunodeficiencies Registry Working Party

.

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

.

J Allergy Clin Immunol

.

2014

;

134

(

1

):

116

-

126

.

8.

Resnick

ES

,

Moshier

EL

,

Godbold

JH

,

Cunningham-Rundles

C.

Morbidity and mortality in common variable immune deficiency over 4 decades

.

Blood

.

2012

;

119

(

7

):

1650

-

1657

.

9.

Wehr

C

,

Kivioja

T

,

Schmitt

C

, et al.

The EUROclass trial: defining subgroups in common variable immunodeficiency

.

Blood

.

2008

;

111

(

1

):

77

-

85

.

10.

Cols

M

,

Rahman

A

,

Maglione

PJ

, et al.

Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency

.

J Allergy Clin Immunol

.

2016

;

137

(

4

):

1206

-

1215.e61215e6

.

11.

Smith

T

,

Cunningham-Rundles

C.

Lymphoid malignancy in common variable immunodeficiency in a single-center cohort

.

Eur J Haematol

.

2021

;

107

(

5

):

503

-

516

.

12.

Ho

H-E

,

Cunningham-Rundles

C.

Seeking relevant biomarkers in common variable immunodeficiency

.

Front Immunol

.

2022

;

13

:

857050

.

13.

Remiker

A

,

Bolling

K

,

Verbsky

J.

Common variable immunodeficiency

.

Med Clin North Am

.

2024

;

108

(

1

):

107

-

121

.

14.

Uzzan

M

,

Ko

HM

,

Mehandru

S

,

Cunningham-Rundles

C.

Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD)

.

Curr Gastroenterol Rep

.

2016

;

18

(

4

):

17

.

15.

Chapel

H

,

Lucas

M

,

Lee

M

, et al.

Common variable immunodeficiency disorders: division into distinct clinical phenotypes

.

Blood

.

2008

;

112

(

2

):

277

-

286

.

16.

Franzblau

LE

,

Fuleihan

RL

,

Cunningham-Rundles

C

,

Wysocki

CA

.

CVID-associated intestinal disorders in the USIDNET registry: an analysis of disease manifestations, functional status, comorbidities, and treatment

.

J Clin Immunol

.

2023

;

44

(

1

):

32

.

17.

Abolhassani

H

,

Hammarström

L

,

Cunningham-Rundles

C.

Current genetic landscape in common variable immune deficiency

.

Blood

.

2020

;

135

(

9

):

656

-

667

.

18.

Rojas-Restrepo

J

,

Caballero-Oteyza

A

,

Huebscher

K

, et al.

Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: experience from a monocentric study

.

Front Immunol

.

2021

;

12

:

786516

.

19.

Maffucci

P

,

Filion

CA

,

Boisson

B

, et al.

Genetic diagnosis using whole exome sequencing in common variable immunodeficiency

.

Front Immunol

.

2016

;

7

:

220

.

20.

Tuijnenburg

P

,

Lango Allen

H

,

Burns

SO

, et al.

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

.

J Allergy Clin Immunol

.

2018

;

142

(

4

):

1285

-

1296

.

21.

Ramirez

NJ

,

Posadas-Cantera

S

,

Caballero-Oteyza

A

,

Camacho-Ordonez

N

,

Grimbacher

B.

There is no gene for CVID - novel monogenetic causes for primary antibody deficiency

.

Curr Opin Immunol

.

2021

;

72

:

176

-

185

.

22.

Picard

C

,

Bobby Gaspar

H

,

Al-Herz

W

, et al.

International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

.

J Clin Immunol

.

2018

;

38

(

1

):

96

-

128

.

23.

Maffucci

P

,

Bigio

B

,

Rapaport

F

, et al.

Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis

.

Proc Natl Acad Sci U S A

.

2019

;

116

(

3

):

950

-

959

.

24.

Garcia-Carmona

Y

,

Chavez

JL

,

Gernez

Y

,

Geyer

JT

,

Bussel

JB

,

Cunningham-Rundles

C.

Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia

.

Blood Adv

.

2024

:bloodadvances.2024013301.

25.

Zhang

L

,

Radigan

L

,

Salzer

U

, et al.

Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes

.

J Allergy Clin Immunol

.

2007

;

120

(

5

):

1178

-

1185

.

26.

Salzer

U

,

Grimbacher

B.

TACI deficiency - a complex system out of balance

.

Curr Opin Immunol

.

2021

;

71

:

81

-

88

.

27.

Boileau

J

,

Mouillot

G

,

Gérard

L

, et al;

DEFI Study Group

.

Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study

.

J Autoimmun

.

2011

;

36

(

1

):

25

-

32

.

28.

Agarwal

S

,

Cunningham-Rundles

C.

Autoimmunity in common variable immunodeficiency

.

Ann Allergy Asthma Immunol

.

2019

;

123

(

5

):

454

-

460

.

29.

Cunningham-Rundles

C.

How I treat common variable immune deficiency

.

Blood

.

2010

;

116

(

1

):

7

-

15

.

30.

Gobert

D

,

Bussel

JB

,

Cunningham-Rundles

C

, et al.

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients

.

Br J Haematol

.

2011

;

155

(

4

):

498

-

508

.

31.

Pecoraro

A

,

Crescenzi

L

,

Galdiero

MR

, et al.

Immunosuppressive therapy with rituximab in common variable immunodeficiency

.

Clin Mol Allergy

.

2019

;

17

:

9

.

32.

Wong

GK

,

Goldacker

S

,

Winterhalter

C

, et al;

Clinical Working Party of the European Society for Immunodeficiencies (ESID)

.

Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients

.

Clin Exp Immunol

.

2013

;

172

(

1

):

63

-

72

.

33.

Salzer

U

,

Bacchelli

C

,

Buckridge

S

, et al.

Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes

.

Blood

.

2009

;

113

(

9

):

1967

-

1976

.

34.

Salzer

U

,

Chapel

HM

,

Webster

AD

, et al.

Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

.

Nat Genet

.

2005

;

37

(

8

):

820

-

828

.

35.

Schwab

C

,

Gabrysch

A

,

Olbrich

P

, et al.

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects

.

J Allergy Clin Immunol

.

2018

;

142

(

6

):

1932

-

1946

.

36.

Lorenzini

T

,

Fliegauf

M

,

Klammer

N

, et al;

NIHR

BioResource

.

Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

.

J Allergy Clin Immunol

.

2020

;

146

(

4

):

901

-

911

.

37.

Klemann

C

,

Camacho-Ordonez

N

,

Yang

L

, et al.

Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2

.

Front Immunol

.

2019

;

10

:

297

.

38.

Fabre

A

,

Marchal

S

,

Barlogis

V

, et al.

Clinical aspects of STAT3 gain-of- function germline mutations: a systematic review

.

J Allergy Clin Immunol Pract

.

2019

;

7

(

6

):

1958

-

1969.e91969e9

.

39.

Jamee

M

,

Moniri

S

,

Zaki-Dizaji

M

, et al.

Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review

.

Clin Rev Allergy Immunol

.

2020

;

59

(

3

):

323

-

333

.

40.

Habibi

S

,

Zaki-Dizaji

M

,

Rafiemanesh

H

, et al.

Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review

.

J Allergy Clin Immunol Pract

.

2019

;

7

(

7

):

2379

-

2386.e52386e5

.

41.

Kuehn

HS

,

Boast

B

,

Rosenzweig

SD

.

Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency

.

Clin Exp Immunol

.

2023

;

212

(

2

):

129

-

136

.

42.

Leiding

JW

,

Vogel

TP

,

Santarlas

VGJ

, et al;

STAT3 GOF Working Group members

.

Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome

.

J Allergy Clin Immunol

.

2023

;

151

(

4

):

1081

-

1095

.

43.

Rao

VK

,

Kulm

E

,

Grossman

J

, et al.

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

.

Blood Adv

.

2024

;

8

(

12

):

3092

-

3108

.

44.

Costagliola

G

,

Cappelli

S

,

Consolini

R.

Autoimmunity in primary immunodeficiency disorders: an updated review on pathogenic and clinical implications

.

J Clin Med

.

2021

;

10

(

20

).

45.

Del Pino-Molina

L

,

Rodríguez-Ubreva

J

,

Torres Canizales

J

, et al.

Impaired CpG demethylation in common variable immunodeficiency associates with B cell phenotype and proliferation rate

.

Front Immunol

.

2019

;

10

:

878

.

46.

Macpherson

ME

,

Halvorsen

B

,

Yndestad

A

, et al.

Impaired HDL function amplifies systemic inflammation in common variable immunodeficiency

.

Sci Rep

.

2019

;

9

(

1

):

9427

.

47.

Rodríguez-Ubreva

J

,

Arutyunyan

A

,

Bonder

MJ

, et al.

Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses

.

Nat Commun

.

2022

;

13

(

1

):

1779

.

48.

Macpherson

ME

,

Skarpengland

T

,

Hov

JR

, et al.

Increased plasma levels of triglyceride-enriched lipoproteins associate with systemic inflammation, lipopolysaccharides, and gut dysbiosis in common variable immunodeficiency

.

J Clin Immunol

.

2023

;

43

(

6

):

1229

-

1240

.

49.

Jørgensen

SF

,

Fevang

B

,

Aukrust

P.

Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications

.

J Clin Immunol

.

2019

;

39

(

1

):

30

-

36

.

50.

Ho

H-E

,

Radigan

L

,

Bongers

G

,

El-Shamy

A

,

Cunningham-Rundles

C.

Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency

.

JCI Insight

.

2021

;

6

(

19

).